(Q34066409)

30 July 2017

Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma (English)

1 reference

30 July 2017

1 reference

Rita A Sakr

1

1 reference

30 July 2017

Violetta Barbashina

2

1 reference

30 July 2017

Mary Morrogh

3

1 reference

30 July 2017

Sarat Chandarlapaty

4

1 reference

30 July 2017

Victor P Andrade

5

1 reference

30 July 2017

Crispinita D Arroyo

6

1 reference

30 July 2017

Narciso Olvera

7

1 reference

30 July 2017

Tari A King

8

1 reference

30 July 2017

1 July 2010

1 reference

Applied Immunohistochemistry & Molecular Morphology

30 July 2017

1 reference

30 July 2017

18

1 reference

30 July 2017

371-374

1 reference

30 July 2017

4

1 reference

describes a project that uses

30 July 2017

1 reference

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Human cancer, PTEN and the PI-3 kinase pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Loss of PTEN expression as a prognostic marker for tongue cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Reduced expression of PTEN correlates with breast cancer progression

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921801

Promoter methylation of the PTEN gene is a common molecular change in breast cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20216404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20216404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/PAI.0B013E3181D50BD5

1 reference

30 July 2017

1 reference

30 July 2017

1 reference